MTOR and autoimmune polyendocrinopathy: There are data showing that, despite adequate anticoagulation renal transplant, recipients with APS continued to develop vascular lesions resulting in graft deterioration, thus maintaining immuno-suppression based on inhibition of the mechanistic target of rapamycin (mTOR-i) complex pathway has been proposed [24].